Clinical Trials

Showing trials with last updates posted in 2025.

NCT02973997 | COMPLETED | PHASE2
57 participants

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Study Type:
INTERVENTIONAL
Last Updated:
2025-08-29
Start Date:
2018-02-07
Completion:
2022-08-15
Conditions
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • Follicular Variant Thyroid Gland Papillary Carcinoma
  • Metastatic Thyroid Gland Follicular Carcinoma
  • Metastatic Thyroid Gland Papillary Carcinoma
  • Poorly Differentiated Thyroid Gland Carcinoma
  • Recurrent Differentiated Thyroid Gland Carcinoma
  • Recurrent Thyroid Gland Follicular Carcinoma
  • Recurrent Thyroid Gland Papillary Carcinoma
  • Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
  • Stage III Thyroid Gland Follicular Carcinoma AJCC v7
  • Stage III Thyroid Gland Papillary Carcinoma AJCC v7
  • Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
  • Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
  • Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
  • Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
  • Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
  • Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
  • Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
  • Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
  • Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
  • Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
  • Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
  • Tall Cell Variant Thyroid Gland Papillary Carcinoma
  • Thyroid Gland Hurthle Cell Carcinoma
  • Unresectable Differentiated Thyroid Gland Carcinoma
  • Unresectable Thyroid Gland Carcinoma
Interventions
  • OTHER
  • DRUG
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page